"Advanced treatment for medication resistant depression which includes Transcranial Magnetic Stimulation (TMS), esKetamine and Ketamine treatments."

During the past decade, Kadima Neuropsychiatry Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kadima Neuropsychiatry Institute" #1 sponsor was "COMPASS Pathways" with 3 trials, followed by "Mind Medicine, Inc." with 1 trials sponsored, "Mindstrong" with 1 trials sponsored, "Neurolief Ltd." with 1 trials sponsored and "Perception Neuroscience" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kadima Neuropsychiatry Institute" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator, "Kadima Neuropsychiatry Institute" with 1 trials as a collaborator and "Precision For Medicine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kadima Neuropsychiatry Institute" are "Treatment Resistant Depression" (4 trials), "Major Depressive Disorder" (2 trials), "Anxiety Generalized" (1 trials), "Bipolar Disorder" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Kadima Neuropsychiatry Institute" in a lesser frequency.

Most popular intervention types in "Kadima Neuropsychiatry Institute" are "Drug" (4 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Psilocybin" (2 trials), "Health by Mindstrong" (1 trials), "MM-120 (LSD D-Tartrate)" (1 trials) and "PCN-101" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kadima Neuropsychiatry Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kadima Neuropsychiatry Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kadima Neuropsychiatry Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kadima Neuropsychiatry Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".